Pharmacologic prevention of perinatal HIV infection

NY Rakhmanina, John van den Anker

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Scopus)

Abstract

The goal of antiretroviral therapy for the prevention of mother-to-child transmission (PMTCT) of HIV is to achieve maximal suppression of maternal viral load with minimal maternal, fetal and infant toxicity during pregnancy, delivery and postpartum. In addition to the efficacy and toxicity of antiretroviral therapy, the consideration of HIV resistance in mothers and infected newborns further complicates therapeutic choices for PMTCT. This manuscript summarizes current approaches to PMTC in diverse international settings. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
Original languageUndefined/Unknown
Pages (from-to)S13-S15
JournalEarly Human Development
Volume90
Publication statusPublished - 2014

Cite this